During the last decade, proteolytic products of the amyloid precursor protein (APP) different from beta amyloid (Aβ) became the targets of Alzheimer’s disease (AD) research, as Aβ could not be proven to possess a decisive role in the AD pathomechanism. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.